<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26312697</article-id>
      <article-id pub-id-type="pmc">4540531</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153504</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Disseminated cutaneous atypical mycobacteriosis by <italic>M.
chelonae</italic> after sclerotherapy of varicose veins in a immunocompetent
patient: a case report<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Murback</surname>
            <given-names>Nathalia Dias Negr&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Higa J&#xFA;nior</surname>
            <given-names>Minoru German</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pomp&#xED;lio</surname>
            <given-names>Maur&#xED;cio Ant&#xF4;nio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cury</surname>
            <given-names>Eunice Stella Jardim</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hans Filho</surname>
            <given-names>Gunter</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takita</surname>
            <given-names>Luiz Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label>Federal University of Mato Grosso do Sul (UFMS) - Campo
Grande (MS), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Nathalia Dias Negr&#xE3;o Murback, Av. Felinto Muller, 1,
79000-000 - Campo Grande - MS, Brazil. E-mail:
<email>nmurback@yahoo.com.br</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>3 Suppl 1</issue>
      <fpage>138</fpage>
      <lpage>142</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>3</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>6</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Atypical mycobacteria are saprophytic organisms not transmitted from person to
person, which affect mainly immunosuppressed but also immunocompetent individuals. We
present a case of atypical mycobacteriosis after a vascular procedure, with
widespread cutaneous lesions associated with polyarthralgia. Mycobacterium chelonae
was identified by the polymerase chain reaction (PCR) method. The patient showed
improvement after treatment with three antibiotics. Mycobacterium chelonae causes
skin lesions after invasive procedures. The clinical form depends on the immune state
of the host and on the entry points. The diagnosis is based essentially on culture
and the mycobacteria is identified by PCR. We highlight the importance of
investigating atypical mycobacteriosis when faced with granulomatous lesions
associated with a history of invasive procedures.</p>
      </abstract>
      <kwd-group>
        <kwd>Bloodless medical and surgical procedures</kwd>
        <kwd>Diagnosis</kwd>
        <kwd>Diagnostic services</kwd>
        <kwd>Elective surgical procedures</kwd>
        <kwd>History</kwd>
        <kwd>Microbiology</kwd>
        <kwd>Mycobacterium infections, nontuberculous</kwd>
        <kwd>Epidemiology</kwd>
        <kwd>Therapeutics</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Opportunistic mycobacteria - also called atypical or environmental mycobacteria - are
referred to as non-tuberculous mycobacteria (NTM) and represent 10% of all
mycobacterioses.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> They are
saprophytic organisms not transmitted from person to person.<sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>NTM cause lung disease, lymphadenopathy, skin and soft tissue lesions. Since they are
opportunistic pathogens, they affect immunosuppressed individuals. Moreover, the number
of disseminated cases increased significantly over time. <sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup> Immunocompetent
individuals are also affected, especially when undergoing invasive procedures. In these
cases, they are usually restricted to the skin and underlying tissues. <sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup> The increasing number of cases is
explained by the HIV/AIDS pandemic associated with the high number of surgeries and
cosmetic procedures performed with medical equipments not properly sterilized.
<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>About 50 NTM species are known and only a few of them are pathogenic for man. The
species most commonly associated with skin diseases are: <italic>M. marinum, M.
ulcerans, M. fortuitum, M. chelonae and M. abscessus.</italic>
<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>The diagnosis of cutaneous infection by NTM remains a challenge, especially in
immunocompromised individuals, due to the large number of differential diagnoses.
<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>We present the first report in the literature of atypical mycobacteriosis by M. chelonae
after sclerotherapy of varicose veins. It is noteworthy that the cutaneous dissemination
occurred in an immunocompetent patient.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 57-year-old female patient reported the appearance of lumps in her left leg, followed
by lesions on the forearms, wrists, thighs and the face, associated with polyarthralgia,
especially in the knees and in the joints of both hands, with significant functional
limitation. The patient had undergone sclerotherapy of varicose veins 40 days before the
onset of symptoms.</p>
      <p>Ectoscopic examination revealed erythematous vioulaceous, indurated and fistulized
papules, nodules and plaques - some of which had sero-hematic crusts - on the forearms,
wrists and lower limbs, and in the left temporo-malar region. There was a slight joint
swelling in the knees and joints of the hands (<xref ref-type="fig" rid="f01">Figure
1</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Cutaneous manifestations. Confl uent, erythematous vioulaceous, indurated nodules
and plaques - some of which were fi stulized - in the posterior region of left leg
<bold>(A)</bold>, on the extensor surface of the wrist <bold>(B)</bold>, and in
the left temporo-malar region A <bold>(C)</bold></p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0138-g01"/>
      </fig>
      <p>Tuberculin test was non-reactive. Serology for infectious diseases and BAAR test were
negative. Autoantibodies were non-reactive. Rheumatoid factor showed a slight increase
(22 IU / ml). ESR of 44 mm/hour and CRP (C reactive protein) of 15.2. A punch biopsy of
the facial lesion was performed. Bacterial culture revealed coagulase-negative
Staphylococcus. Fungal culture was negative. Positive AFB smear. A culture on
Lowenstein-Jensen medium showed a growth of mycobacteria, identified by PCR with partial
rpoB gene sequencing as Mycobacterium chelonae.</p>
      <p>Histopathologic examination revealed granulomatous inflammation in the dermis, with
multinucleated giant cells and areas of necrosis. Culture was negative for fungi and
parasites. AFB smear was negative, as well as immunohistochemistry for Leishmania spp
and mycobacteria (<xref ref-type="fig" rid="f02">Figures 2</xref> and <xref ref-type="fig" rid="f03">3</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Histopathology (40x). Granulomatous infl ammatory infi ltrate, with several
multinucleated giant cells and areas of necrosis in the deep dermis</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0138-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Histopathology (100x). Granulomatous infl ammatory infi ltrate with xanthomatous
histiocytes</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0138-g03"/>
      </fig>
      <p>Computed tomography was nonspecific. Bone scintigraphy showed radiotracer
hyperconcentration in multiple joints (<xref ref-type="fig" rid="f04">Figure
4</xref>).</p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Three-phase bone scintigraphy. Moderate focal hyperconcentration in T7, T9 and L5.
Mild hyperconcentration in T4, T5 and S1. Marked diffuse hyperconcentration in the
right ankle. Moderate diffuse hyperconcentration in the right knee and tarsal
bones. Mild diffuse hyperconcentration in the shoulders, thoracic and lumbar
vertebrae, and left knee</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0138-g04"/>
      </fig>
      <p>After a sixth-month treatment with ciprofloxacin (400 mg twice daily IV) and
clarithromycin (500 mg twice daily orally) and a two-month treatment with amikacin
(1g/day IV),lesions healed, inflammatory markers normalized and arthralgias persisted
with lower intensity.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>M. chelonae is a rapidly growing mycobacteria (RGM) included in group IV of
Runyon&gt;s classification and widely distributed in nature. It is found in the water,
soil, in animals and bioaerosols, and even under supposedly adverse conditions, such as
low pH and varying temperatures. It often causes skin lesions after invasive procedures
and may be resistant to the usual methods of disinfection and sterilization. <sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>There are several reports of outbreaks caused by NTM after surgeries. In Brazil, we
highlight the outbreaks that occurred in S&#xE3;o Paulo (2003-2004), Par&#xE1; (2004), Rio de
Janeiro (2006) and Esp&#xED;rito Santo (2007). Flaws in the techniques of disinfection and
sterilization of materials were detected. <sup><xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r08" ref-type="bibr">8</xref></sup>
<xref ref-type="fig" rid="f05">Graph 1</xref> shows the distribution of reported cases
of infection by RGM from 1998-2009 in Brazil. We can see that cases were more prevalent
in the years 2006-2008. During this period, there were 13 cases of M. chelonae. The mean
age of patients was 51 years, 100% of them were female, and cosmetic injection to the
face was the most common procedure. <sup><xref rid="r09" ref-type="bibr">9</xref></sup></p>
      <fig id="f05" orientation="portrait" position="float">
        <label>GRAPH 1</label>
        <caption>
          <p>Cases reported from invasive procedures. Distribution of reported cases of
infection by rapidly growing mycobacteria associated with invasive procedures,
according to the year of the procedure. Brazil, 1998-2009</p>
        </caption>
        <graphic xlink:href="abd-90-03-s1-0138-g05"/>
      </fig>
      <p>NTM occur in the presence or absence of immunosuppression, although they are more
frequent in the first situation. 5 The clinical form depends on the immune state of the
host, on the type of mycobacterium and on the entry points. In immunocompetent
individuals, the infection is usually localized, with one or multiple entry points, such
as in acupuncture, mesotherapy and tattoos. In immunocompromised individuals, the
infection is usually widespread. <sup><xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>The vascular procedure performed 40 days before the onset of lesions may be considered
the possible transmission path. This incubation period is expected, according to the
literature. <sup><xref rid="r05" ref-type="bibr">5</xref></sup> Although the patient was
immunocompetent, she had wiedespread skin infection. A hypothesis to explain this would
be the manipulation of initial lesions by the patient and implantation of the agent in
other body sites.</p>
      <p>The most common clinical presentation - at the site of inoculation - are painless,
fistulized nodules and abscesses. These are not accompanied by poor general condition or
involvement of internal organs. <sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup> Bone scintigraphy revealed arthritis and
inflammatory foci. Previous radiographs showed signs of arthrosis. A hypothesis would be
prior joint disease exacerbated by superimposed reactive arthritis, which led to a
thorough investigation of diseases such as rheumatoid arthritis and systemic lupus
erythematosus.</p>
      <p>The diagnosis is based on the histopathology findings and, essentially, on the culture
of skin materials. Smear microscopy is usually negative. <sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup> Species
identification is important because it guides laboratory analysis and demonstrates the
antimicrobial susceptibility profiles.<sup><xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>Smear microscopy can be performed by Ziehl-Neelsen stain. A disadvantage of this method
is that it does not morphologically differentiate between species. Species
identification is done by phenotypic and/or molecular methods. <sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>Cultures can be made in several media, such as thioglycolate broth, blood agar,
chocolate agar, Mac-Conkey agar and Lowenstein-Jensen medium. The latter is specific for
mycobacteria.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> In addition to
performing antimicrobial assays, they allow the identification of species by DNA
sequencing. <sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>PCR is a sensitive and specific molecular method that has been used for detection of
mycobacteria. Multiplex PCR enables the detection of multiple DNA sequences in a single
reaction, with greater speed and specificity. <sup><xref rid="r05" ref-type="bibr">5</xref></sup> For the identification of RGM, the rpoB gene should be used,
whereas for the identification of slow-growing mycobacteria the hsp65 gene should be
employed. <sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Treatment is not standardized. Two or three antimicrobials may be associated according
to the antibiogram. Regimens with clarithromycin used continuously for four to six
months have been encouraged.<sup><xref rid="r02" ref-type="bibr">2</xref></sup>
Combination therapy with other antibiotics is preferable in order to prevent resistance.
<sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup>
<xref ref-type="table" rid="t01">Chart 1</xref> shows several antimicrobial schemes
suggested according to the site of the lesions, extent of involvement and presence of
comorbidities.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>CHART 1</label>
        <caption>
          <p>Treatment. Antimicrobial schemes proposed according to the site of the lesions,
and the extent and severity of involvement</p>
        </caption>
        <table frame="box" rules="groups">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1"><bold>Site, extent, severity</bold>&#xA0;</td>
              <td rowspan="1" colspan="1"><bold>Proposed antimicrobial schemes</bold>&#xA0;</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Single lesion limited to the skin and subcutaneous tissue<xref ref-type="table-fn" rid="TFN04">*</xref>&#xA0;</td>
              <td rowspan="1" colspan="1">Clarithromycin 500 mg twice daily PO for 6 months</td>
            </tr>
            <tr>
              <td rowspan="3" colspan="1">Multiple lesions limited to the skin and subcutaneous
tissue<xref ref-type="table-fn" rid="TFN04">*</xref>&#xA0;</td>
              <td rowspan="1" colspan="1">- Include 2 antimicrobials: </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">1. Clarithromycin 500 mg twice daily PO for at least 6 months; </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2. 15mg/kg up to 1g/dose once daily IM or IV for 1 week, beginning
intraoperatively after collecting material for microbiological examination.
Then 3 times weekly for 1-2 months<xref ref-type="table-fn" rid="TFN05">**</xref>.</td>
            </tr>
            <tr>
              <td rowspan="4" colspan="1">Deep wound infection involving the fascia and muscle,
in-tra-peritoneal involvement or evidence of spread, and in cases of
arthritis or osteomyelitis, or patients with greater severity of
illness</td>
              <td rowspan="1" colspan="1">- Include 3 antimicrobials:</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">1. Clarithromycin 500 mg twice daily IV </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2. Amikacin: 15mg/kg up to 1g/dose once daily IM or IV for 2 weeks,
beginning immediately after surgical de-bridement. Then 3 times weekly for
1-2 months<xref ref-type="table-fn" rid="TFN05">**</xref>.</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"> 3. Imipenem (500 mg four times daily IV) for 3-8 weeks.</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN01">
            <p>NOTE: M. chelonae is the only species to which monotherapy with clarithromycin
can be implemented without surgical debridement.</p>
          </fn>
          <fn id="TFN02">
            <p>Source: Brasil, 2009.10</p>
          </fn>
          <fn id="TFN03">
            <p>PO: orally; IV: intravenous; IM: intramuscular</p>
          </fn>
          <fn id="TFN04">
            <label>*</label>
            <p>absence of prosthesis or other foreign body.</p>
          </fn>
          <fn id="TFN05">
            <label>**</label>
            <p>The use of amikacin may be extended for up to six months, according to the
progress of the case and the physician&#x2019;s discretion.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>We highlight the importance of investigating atypical mycobacteriosis when faced with
granulomatous lesions associated with a history of invasive procedures.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Murback NDN, Higa J&#xFA;nior MG, Pomp&#xED;lio MA, Cury
ESJ, Hans Filho G, Takita LC. Disseminated cutaneous atypical mycobacteriosis by M.
chelonae after sclerotherapy of varicose veins in a immunocompetent patient: a case
report . An Bras Dermatol. 2015;90 (3 Suppl 1):S138-42.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Study conducted at the University Hospital Center - Federal University of Mato Grosso
do Sul (NHU-UFMS) - Campo Grande (MS), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sampaio</surname>
              <given-names>SAP</given-names>
            </name>
            <name>
              <surname>Rivitti</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <source>Dermatologia</source>
          <edition>3. ed</edition>
          <publisher-loc>S&#xE3;o Paulo</publisher-loc>
          <publisher-name>Artes M&#xE9;dicas</publisher-name>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olivares</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fandi&#xF1;o</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pardal</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Corti&#xF1;as</surname>
              <given-names>MEP</given-names>
            </name>
            <name>
              <surname>Maronna</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Infecci&#xF3;n cut&#xE1;nea por Mycobacterium chelonae</article-title>
          <source>Dermatol. Argent</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>446</fpage>
          <lpage>450</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chichotky</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ca&#xF1;ete</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Velasco Zamora</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Velasco Zamora</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cuando lo t&#xED;pico es tambi&#xE9;n at&#xED;pico: vasculitis asociada a infecci&#xF3;n
cut&#xE1;nea por micobacteria at&#xED;pica</article-title>
          <source>AR Artritis Reumatoidea</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>26</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Duarte</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Baudrier</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sim&#xF5;es</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>A cutaneous infection by Mycobacterium chelonae in a patient with
rheumatoid arthritis</article-title>
          <source>Dermatol Online J</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>3</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">20409410</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poroca Dda</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Cruz</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Montenegro Rde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>FL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differentiation of micobacteria by multiplex PCR</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2009</year>
          <volume>42</volume>
          <fpage>716</fpage>
          <lpage>722</lpage>
          <pub-id pub-id-type="pmid">20209361</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontana</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>The Mycobacterias of Rapid Growth and the hospital infection: a public
health problem</article-title>
          <source>Rev Bras Enferm</source>
          <year>2008</year>
          <volume>61</volume>
          <fpage>371</fpage>
          <lpage>376</lpage>
          <pub-id pub-id-type="pmid">18604436</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macedo</surname>
              <given-names>JLS</given-names>
            </name>
            <name>
              <surname>Maierovitch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Henriques</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Infec&#xE7;&#xF5;es p&#xF3;s-operat&#xF3;rias por micobact&#xE9;rias de crescimento r&#xE1;pido no
Brasil</article-title>
          <source>Rev Bras Cir Pl&#xE1;st</source>
          <year>2009</year>
          <volume>24</volume>
          <fpage>544</fpage>
          <lpage>551</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macadam</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Mehling</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Fanning</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dufton</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kowalewska-Grochowska</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Lennox</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nontuberculous Mycobacterial Breast Implant Infections</article-title>
          <source>Plast Reconstr Surg</source>
          <year>2007</year>
          <volume>119</volume>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">17255691</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Ag&#xEA;ncia Nacional de Vigil&#xE2;ncia Sanit&#xE1;ria (Anvisa)</collab>
          </person-group>
          <source>Relat&#xF3;rio descrito de investiga&#xE7;&#xE3;o de casos de infec&#xE7;&#xF5;es por micobact&#xE9;rias
n&#xE3;o tuberculosas de crescimento r&#xE1;pido (MCR) no Brasil no per&#xED;odo de 1998 a
2009</source>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Anvisa</publisher-name>
          <year>2011</year>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil</collab>
            <collab>Ag&#xEA;ncia Nacional de Vigil&#xE2;ncia Sanit&#xE1;ria (Anvisa)</collab>
            <collab>Minist&#xE9;rio da Sa&#xFA;de</collab>
            <collab>Secretaria de Vigil&#xE2;ncia em Sa&#xFA;de</collab>
          </person-group>
          <source>Nota t&#xE9;cnica conjunta n 1/2009 - Svs/Ms e Anvisa. Infec&#xE7;&#xF5;es por micobact&#xE9;rias
de crescimento r&#xE1;pido: fluxo de notifica&#xE7;&#xF5;es, diagn&#xF3;sticos cl&#xED;nico, microbiol&#xF3;gico
e tratamento</source>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Anvisa</publisher-name>
          <year>2009</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
